CTOs on the Move


 
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kapost.com
  • 1800 Broadway Suite 180
    Boulder, CO USA 80302
  • Phone: 720.408.0222

Executives

Name Title Contact Details

Funding

Kapost raised $10M on 05/13/2015

Similar Companies

Lee County Bank

At Lee County Bank, we treat you like a friend, not just an account number.

Acard technology

Acard technology is a Placentia, CA-based company in the Software and Internet sector.

Ledgible

Ledgible Crypto Tax and Accounting platform provides professionals and individuals tools to monitor cryptocurrency along with tax reporting.

YouAppi

Finding the most valuable customers is difficult and it takes intelligent technology to understand the user purchasing habits. YouAppi focuses solely on customer acquisition for mobile app owners. YouAppi drives the acquisition and conversion of the most profitable mobile customers through our proprietary predictive algorithms and analysis of the usage habits of 1.1 billion mobile users. Our OneRun™ Platform delivers higher Customer Lifetime Value (LTV) and the ability to scale customer acquisition with greater insight and control over revenue. YouAppi`s global team is based in San Francisco,New York City, London, Berlin and Israel.